Alcidion Group Limited (AU:ALC) has released an update.
Alcidion Group Limited reported new sales of $5.2 million in Q1 FY25, with significant contracts like a $4 million deal with Hume Rural Health Alliance. The company ended the quarter with a cash balance of $7.9 million and no debt, while aiming for an EBITDA positive outcome in FY25 with a breakeven revenue target of $36 million. Alcidion’s strategic focus on digital healthcare platforms signals promising growth opportunities in the ANZ and UK markets.
For further insights into AU:ALC stock, check out TipRanks’ Stock Analysis page.
The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.
